Toronto, Ontario–(Newsfile Corp. – February 23, 2021) – Aion Therapeutic Inc. (CSE: AION) (“Aion Therapeutic” or the “Company“) announced today the opening of the Aion International Center for Psychedelic Psychiatry in Jamaica. The Center will initially specialize in the use of psilocybin for the treatment of addiction (tobacco, alcohol, and other drug misuse), depression and anxiety associated…


Previous articleA New Path To Wealth: Navigating The Psychedelic Investment Landscape
Next articleCatching Up With the Psychedelic Entourage Effect: Part 5 – MindMed